ASO Author Reflections: Entering the Era of Biomarker-Driven Management of the Axilla.
Publication
, Journal Article
DiNome, ML; Marzese, DM
Published in: Ann Surg Oncol
August 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Ann Surg Oncol
DOI
EISSN
1534-4681
Publication Date
August 2022
Volume
29
Issue
8
Start / End Page
4725 / 4726
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Neoadjuvant Therapy
- Humans
- Female
- Breast Neoplasms
- Biomarkers
- Axilla
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
DiNome, M. L., & Marzese, D. M. (2022). ASO Author Reflections: Entering the Era of Biomarker-Driven Management of the Axilla. Ann Surg Oncol, 29(8), 4725–4726. https://doi.org/10.1245/s10434-022-11767-y
DiNome, Maggie L., and Diego M. Marzese. “ASO Author Reflections: Entering the Era of Biomarker-Driven Management of the Axilla.” Ann Surg Oncol 29, no. 8 (August 2022): 4725–26. https://doi.org/10.1245/s10434-022-11767-y.
DiNome ML, Marzese DM. ASO Author Reflections: Entering the Era of Biomarker-Driven Management of the Axilla. Ann Surg Oncol. 2022 Aug;29(8):4725–6.
DiNome, Maggie L., and Diego M. Marzese. “ASO Author Reflections: Entering the Era of Biomarker-Driven Management of the Axilla.” Ann Surg Oncol, vol. 29, no. 8, Aug. 2022, pp. 4725–26. Pubmed, doi:10.1245/s10434-022-11767-y.
DiNome ML, Marzese DM. ASO Author Reflections: Entering the Era of Biomarker-Driven Management of the Axilla. Ann Surg Oncol. 2022 Aug;29(8):4725–4726.
Published In
Ann Surg Oncol
DOI
EISSN
1534-4681
Publication Date
August 2022
Volume
29
Issue
8
Start / End Page
4725 / 4726
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Neoadjuvant Therapy
- Humans
- Female
- Breast Neoplasms
- Biomarkers
- Axilla
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis